AI assistant
Sending…
IMMUNIC, INC. — Director's Dealing 2015
Jul 15, 2015
10196_dirs_2015-07-15_f44d1f16-673f-49d5-8676-69b6df93acfc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: VITAL THERAPIES INC (VTL)
CIK: 0001280776
Period of Report: 2015-07-14
Reporting Person: Cohen Cheryl (Director)
More from IMMUNIC, INC.
Regulatory Filings
2026
May 28
Board/Management Information
2026
May 27
Board/Management Information
2026
May 19
Report Publication Announcement
2026
May 13
Interim / Quarterly Report
2026
May 13
Earnings Release
2026
May 13
Regulatory Filings
2026
Apr 30
Board/Management Information
2026
Apr 28
Board/Management Information
2026
Apr 28
Share Issue/Capital Change
2026
Apr 23